Thematic 2018 Letter from the Editor

References

• Amsterdam D, Ostrov B. (2018). The impact of the microbiome on immunosenescence. Immunol Invest, 47.
   Google Scholar
• Brandtzaeg P. (2010). Function of mucosa-associated lymphoid tissue in antibody formation. Immunol Invest, 39(4–5), 303–355. doi:10.3109/08820131003680369.
   PubMed Web of Science ®Google Scholar
• Castañeda-Delgado, JE, Frausto-Lujan I, González-Curiel, I, Montoya-Rosales, A, Serrano, CJ, Torres-Juarez, F… & Rivas-Santiago, B. (2017). Differences in cytokine production during aging and its relationship with antimicrobial peptides production. Immunol Invest, 46(1), 48–58. doi:10.1080/08820139.2016.1212873.
   PubMed Web of Science ®Google Scholar
• Chodon T, Koya RC, Odunsi K. (2015). Active immunotherapy of cancer. Immunol Invest, 44(8), 817–836. doi:10.3109/08820139.2015.1096684.
   PubMed Web of Science ®Google Scholar
• Crotti G, Gianfagna F, Bonaccio M, Di Castelnuovo, A, Costanzo, S, Persichillo, M, … & Iacoviello, L. (2018). Body mass index, low-grade inflammation and mortality in elderly subjects. Results from the moli-sani study. Immunol Invest, 47.
   Google Scholar
• Fontana J, Zimab M, Vetvickac V. (2018). Biological markers of oxidative stress in cardiovascular diseases: after so many studies, what do we know? Immunol Invest, 47.
   Google Scholar
• Forsythe, P., & Bienenstock, J (2010). Immunomodulation by commensal and probiotic bacteria. Immunol Invest, 39(4–5), 429–448. doi:10.3109/08820131003667978.
   PubMed Web of Science ®Google Scholar
• Gamal RM, Gamal WM, Ghandour AM, Abozaid, HSM, Mohamed, ME, Emad, Y… & Abdel Galeel, A. (2018). Study of the osteoprotegerin/receptor activator of nuclear factor-kB ligand system association with inflammation and atherosclerosis in systemic sclerosis. Immunol Invest, 47(3), 241–250. doi:10.1080/08820139.2017.1423499.
   PubMed Web of Science ®Google Scholar
• Gao Y, Zhou S, Jiang W, Huang, M, & Dai, X. (2003). Effects of ganopoly® (A Ganoderma lucidum Polysaccharide Extract) on the immune functions in advanced‐stage cancer patients. Immunol Invest, 32(3), 201–215. doi:10.1081/IMM-120022979.
   PubMed Web of Science ®Google Scholar
• Gonzalez OA, Novak MJ, Kirakodu S, Stromberg, A, Nagarajan, R, Huang, CB, … & Ebersole, JL. (2015). Differential gene expression profiles reflecting macrophage polarization in aging and periodontitis gingival tissues. Immunol Invest, 44(7), 643–664. doi:10.3109/08820139.2015.1070269.
   PubMed Web of Science ®Google Scholar
• Haile LA, Greten TF, Korangy F. (2012). Immune suppression: the hallmark of myeloid derived suppressor cells. Immunol Invest, 41(6–7), 581–594. doi:10.3109/08820139.2012.680635.
   PubMed Web of Science ®Google Scholar
• Harden JL, Egilmez NK. (2012). Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity. Immunol Invest, 41(6–7), 738–764. doi:10.3109/08820139.2012.676122.
   PubMed Web of Science ®Google Scholar
• Huiying C, Wang X, Yang S Yang. (2018). miR-350-3p contributes to age-associated impairment of IL-6 production by macrophages. Immunol Invest, 47.
   Google Scholar
• Kirkwood KL, Zhang L, Thiyagarajan R. (2018). Troen myeloid-derived suppressor cells at the intersection of inflammaging and bone fragility. Immunol Invest, 47.
   Google Scholar
• Liu XG, Hou M, Liu Y. (2017). TIGIT, a novel therapeutic target for tumor immunotherapy. Immunol Invest, 46(2), 172–182. doi:10.1080/08820139.2016.1237524.
   PubMed Web of Science ®Google Scholar
• Maccalli C, Parmiani G, Ferrone S. (2017). Immunomodulating and immunoresistance properties of cancer-initiating cells: implications for the clinical success of immunotherapy. Immunol Invest, 46(3), 221–238. doi:10.1080/08820139.2017.1280051.
   PubMed Web of Science ®Google Scholar
• Manohar A, Ahuja J, Crane JK. (2015). Immunotherapy for infectious diseases: past, present, and future. Immunol Invest, 44(8), 731–737. doi:10.3109/08820139.2015.1093914.
   PubMed Web of Science ®Google Scholar
• Meneguello-Coutinho M, Caperuto E, Bacurau AVN, Chamusca, G, Uchida, MC, Tibana, RA, … & Prestes, J. (2014). Effects of dietary restriction or swimming on lymphocytes and macrophages functionality from old rats. Immunol Invest, 43(2), 113–122. doi:10.3109/08820139.2013.847456.
   PubMed Web of Science ®Google Scholar
• Mosaad YM. (2014). Immunology of hematopoietic stem cell transplant. Immunol Invest, 43(8), 858–887. doi:10.3109/08820139.2014.942460.
   PubMed Web of Science ®Google Scholar
• Mosayebi G, Ghazavi A, Ghasami K, Jand, Y, & Kokhaei, P (2011). Therapeutic effect of vitamin D3 in multiple sclerosis patients. Immunol Invest, 40(6), 627–639. doi:10.3109/08820139.2011.573041.
   PubMed Web of Science ®Google Scholar
• Obermajer N, Wong JL, Edwards RP, Odunsi, K, Moysich, K, & Kalinski, P (2012). PGE(2)-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells. Immunol Invest, 41(6–7), 635–657. doi:10.3109/08820139.2012.695417.
   PubMed Web of Science ®Google Scholar
• Park S, Kang S, Min KH, Woo Hwang, K, & Min, H. (2013). Age-associated changes in microRNA expression in bone marrow derived dendritic cells. Immunol Invest, 42(3), 179–190. doi:10.3109/08820139.2012.717328.
   PubMed Web of Science ®Google Scholar
• Raber P, Ochoa AC, Rodríguez PC. (2012). Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and Therapeutic Perspectives. Immunol Invest, 41(6–7), 614–634. doi:10.3109/08820139.2012.680634.
   PubMed Web of Science ®Google Scholar
• Rahbarizadeh F, Ahmadvand D, Sharifzadeh Z. (2011). Nanobody; an old concept and new vehicle for immunotargeting. Immunol Invest, 40(3), 299–338. doi:10.3109/08820139.2010.542228.
   PubMed Web of Science ®Google Scholar
• Salmaninejad A, Zamani MR, Pourvahedi M, Golchehre, Z, Hosseini Bereshneh, A, & Rezaei, N. (2016). Cancer/testis antigens: expression, regulation, tumor invasion, and use in immunotherapy of cancers. Immunol Invest, 45(7), 619–640. doi:10.1080/08820139.2016.1197241.
   PubMed Web of Science ®Google Scholar
• Shahrokhi VH, Ravari A, Mirzaei T, Zare-Bidaki, M, Asadikaram, G, & Arababadi, MK. (2018). IL-17A and IL-23; plausible risk factors to induce age-associated inflammation in Alzheimer disease. Immunol Invest, 47.
   Google Scholar
• Shao M-J, Zhu Y-J, Qiu Y-E, Hu, M, & He, YQ. (2017). Changes in the level of immunoglobulins and CD4/CD8 ratio in young and aged mice with estradiol deficiency. Immunol Invest, 46(3), 305–313. doi:10.1080/08820139.2016.1267203.
   PubMed Web of Science ®Google Scholar
• Sobrinho R, Maurício Da H, Da Silva DJ, Gomides, LF, Dorta, ML, Oliveira, MAPD, …& Ribeiro-Dias, F. (2018). TLR4 and TLR2 activation is differentially associated with age during Parkinson’s disease. Immunol Invest, 47(1), 71–88. doi:10.1080/08820139.2017.1379024.
   PubMed Web of Science ®Google Scholar
• Souza, PP, & Lerner, UH The role of cytokines in inflammatory bone loss. Immunol Invest, 42(7), 555–622. doi:10.3109/08820139.2013.822766.
   PubMed Web of Science ®Google Scholar
• Zhu W, Jianbo Y, Nie Y, Shi, X, Liu, Y, Li, F, …& Zhang, XL. (2014). Disequilibrium of M1 and M2 macrophages correlates with the development of experimental inflammatory bowel diseases. Immunol Invest, 43(7), 638–652. doi:10.3109/08820139.2014.909456.
   PubMed Web of Science ®Google Scholar